|
26
|
|
|
$26.53
|
$70
|
164%
upside
|
Buy
|
6 months ago
|
|
|
27
|
|
|
$235.68
|
$280
|
19%
upside
|
Buy
|
6 months ago
|
|
|
28
|
|
|
$123.38
|
$138
|
12%
upside
|
Buy
|
7 months ago
|
|
|
29
|
Strategy Inc Common Stock Class A
|
|
$327.59
|
$500
|
53%
upside
|
Buy
|
7 months ago
|
|
|
30
|
|
|
$2.61
|
$6
|
130%
upside
|
Buy
|
7 months ago
|
|
|
31
|
|
|
$183.25
|
$245
|
34%
upside
|
Buy
|
7 months ago
|
|
|
32
|
|
|
$69.96
|
$80
|
14%
upside
|
Buy
|
7 months ago
|
|
|
33
|
Rezolve AI PLC Ordinary Shares
|
|
$4.32
|
$10
|
131%
upside
|
Buy
|
7 months ago
|
|
|
34
|
|
|
$7.13
|
$20
|
181%
upside
|
Buy
|
7 months ago
|
|
|
35
|
Lineage Cell Therapeutics
|
|
$1.20
|
$3
|
150%
upside
|
Buy
|
7 months ago
|
|
|
36
|
|
|
$9.27
|
$18
|
94%
upside
|
Buy
|
8 months ago
|
|
|
37
|
|
|
$27.36
|
$17
|
38%
downside
|
Buy
|
8 months ago
|
|
|
38
|
|
|
$65.14
|
$110
|
69%
upside
|
Buy
|
9 months ago
|
|
|
39
|
|
|
$239.78
|
$215
|
10%
downside
|
Hold
|
10 months ago
|
|
|
40
|
|
|
$5.10
|
$12
|
135%
upside
|
Buy
|
10 months ago
|
|
|
41
|
|
|
$5.30
|
$8
|
51%
upside
|
Buy
|
10 months ago
|
|
|
42
|
|
|
$16.69
|
$19
|
14%
upside
|
Buy
|
10 months ago
|
|
|
43
|
|
|
$1.03
|
$4
|
288%
upside
|
Buy
|
10 months ago
|
|
|
44
|
|
|
$5.94
|
$25
|
321%
upside
|
Buy
|
11 months ago
|
|
|
45
|
|
|
$8.93
|
$25
|
180%
upside
|
Buy
|
11 months ago
|
|
|
46
|
|
|
$13.52
|
$12
|
11%
downside
|
Buy
|
11 months ago
|
|
|
47
|
|
|
$87.79
|
$144
|
64%
upside
|
Buy
|
1 year ago
|
|
|
48
|
|
|
$7.38
|
$10
|
36%
upside
|
Buy
|
1 year ago
|
|
|
49
|
|
|
$479.69
|
$445
|
7%
downside
|
Buy
|
1 year ago
|
|
|
50
|
|
|
$16.81
|
$24
|
43%
upside
|
Buy
|
1 year ago
|
|
